Files
Document type
ArticleVersion
Published versionPublication date
All rights reserved
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/132010
Prognostic value of IL-6 in the localized prostatic cancer
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
AIM: The usefulness of interleukin 6 (IL-6) and its soluble receptor IL-6sR in the prediction of the biochemical recurrence was evaluated in patients with prostate cancer treated with radical prostatectomy. PATIENTS AND METHODS: IL-6 and sIL-6R serum levels were measured in 96 patients with prostate cancer. RESULTS: Using the log-rank test, it was evident that patients with preoperative serum levels of IL-6 higher than 1.2 pg/ml had a significantly increased probability of biochemical recurrence (p=0.031). We also observed that the Gleason score was associated with the risk of progression (p=0.033), but no relation was observed with TNM classification, PSA, % free PSA or sIL-6R. In a multivariate analysis, only IL-6 serum levels remained as a predictor of biochemical recurrence (p=0.040). CONCLUSION: The results presented here demonstrated the usefulness of IL-6 in predicting the biochemical progression of prostate cancer, pointing towards an association between inflammation and the aggressiveness of the tumor.
Subject
Subject (English)
Citation
Citation
ALCOVER GARCÍA, Juan, et al. Prognostic value of IL-6 in the localized prostatic cancer. Anticancer Research. 2010. Vol. 30, num. 10, pags. 4369-4372. ISSN 0250-7005. [consulted: 9 of June of 2026]. Available at: https://hdl.handle.net/2445/132010